Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

Factors associated with general surgery residents' decisions regarding fellowship and subspecialty stratified by burnout and quality of life.

McClintock NC, Gray KE, Neville AL, Kaji AH, Wolfe MM, Calhoun KE, Amersi FF, Donahue TR, Arnell TD, Jarman BT, Inaba K, Melcher ML, Morris JB, Smith BR, Reeves ME, Gauvin JM, Salcedo ES, Sidwell RA, Dent DL, Murayama KM, Damewood RB, Poola VP, de Virgilio CM.

Am J Surg. 2019 Aug 8. pii: S0002-9610(19)30357-5. doi: 10.1016/j.amjsurg.2019.08.003. [Epub ahead of print]

PMID:
31421896
2.

Impact of Changes in the American Joint Committee on Cancer Staging Manual, Eighth Edition, for Pancreatic Ductal Adenocarcinoma.

Kassardjian A, Stanzione N, Donahue TR, Wainberg ZA, Damato L, Wang HL.

Pancreas. 2019 Aug;48(7):876-882. doi: 10.1097/MPA.0000000000001349.

PMID:
31268985
3.

Epidural Analgesia Improves Postoperative Pain Control but Impedes Early Discharge in Patients Undergoing Pancreatic Surgery.

Kim SS, Niu X, Elliott IA, Jiang JP, Dann AM, Damato LM, Chung H, Girgis MD, King JC, Hines OJ, Rahman S, Donahue TR.

Pancreas. 2019 May/Jun;48(5):719-725. doi: 10.1097/MPA.0000000000001311.

PMID:
31091221
4.

Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring.

Shi Y, Gao W, Lytle NK, Huang P, Yuan X, Dann AM, Ridinger-Saison M, DelGiorno KE, Antal CE, Liang G, Atkins AR, Erikson G, Sun H, Meisenhelder J, Terenziani E, Woo G, Fang L, Santisakultarm TP, Manor U, Xu R, Becerra CR, Borazanci E, Von Hoff DD, Grandgenett PM, Hollingsworth MA, Leblanc M, Umetsu SE, Collisson EA, Scadeng M, Lowy AM, Donahue TR, Reya T, Downes M, Evans RM, Wahl GM, Pawson T, Tian R, Hunter T.

Nature. 2019 May;569(7754):131-135. doi: 10.1038/s41586-019-1130-6. Epub 2019 Apr 17.

5.

Lysosome inhibition sensitizes pancreatic cancer to replication stress by aspartate depletion.

Elliott IA, Dann AM, Xu S, Kim SS, Abt ER, Kim W, Poddar S, Moore A, Zhou L, Williams JL, Capri JR, Ghukasyan R, Matsumura C, Tucker DA, Armstrong WR, Cabebe AE, Wu N, Li L, Le TM, Radu CG, Donahue TR.

Proc Natl Acad Sci U S A. 2019 Apr 2;116(14):6842-6847. doi: 10.1073/pnas.1812410116. Epub 2019 Mar 20.

6.

A Prognostic Scoring System for the Prediction of Metastatic Recurrence Following Curative Resection of Pancreatic Neuroendocrine Tumors.

Sho S, Court CM, Winograd P, Toste PA, Pisegna JR, Lewis M, Donahue TR, Hines OJ, Reber HA, Dawson DW, Tomlinson JS.

J Gastrointest Surg. 2019 Jul;23(7):1392-1400. doi: 10.1007/s11605-018-4011-7. Epub 2018 Oct 23.

7.

Lysine methyltransferase 2D regulates pancreatic carcinogenesis through metabolic reprogramming.

Koutsioumpa M, Hatziapostolou M, Polytarchou C, Tolosa EJ, Almada LL, Mahurkar-Joshi S, Williams J, Tirado-Rodriguez AB, Huerta-Yepez S, Karavias D, Kourea H, Poultsides GA, Struhl K, Dawson DW, Donahue TR, Fernández-Zapico ME, Iliopoulos D.

Gut. 2019 Jul;68(7):1271-1286. doi: 10.1136/gutjnl-2017-315690. Epub 2018 Oct 18.

8.

Association of Hospital Length of Stay and Complications With Readmission After Open Pancreaticoduodenectomy.

Jiang J, Upfill-Brown A, Dann AM, Kim SS, Girgis MD, King JC, Donahue TR.

JAMA Surg. 2019 Jan 1;154(1):88-90. doi: 10.1001/jamasurg.2018.3213. No abstract available.

9.

Carcinoembryonic Antigen for Diagnosis of Colorectal Cancer Recurrence.

Kim SS, Donahue TR, Girgis MD.

JAMA. 2018 Jul 17;320(3):298-299. doi: 10.1001/jama.2018.8424. No abstract available.

PMID:
30027230
10.

Laparoscopic Cholecystectomy.

Kim SS, Donahue TR.

JAMA. 2018 May 1;319(17):1834. doi: 10.1001/jama.2018.3438. No abstract available.

PMID:
29715356
11.

Dual-Modality Immuno-PET and Near-Infrared Fluorescence Imaging of Pancreatic Cancer Using an Anti-Prostate Stem Cell Antigen Cys-Diabody.

Zettlitz KA, Tsai WK, Knowles SM, Kobayashi N, Donahue TR, Reiter RE, Wu AM.

J Nucl Med. 2018 Sep;59(9):1398-1405. doi: 10.2967/jnumed.117.207332. Epub 2018 Mar 30.

12.

Pasireotide does not prevent postoperative pancreatic fistula: a prospective study.

Elliott IA, Dann AM, Ghukasyan R, Damato L, Girgis MD, King JC, Hines OJ, Reber HA, Donahue TR.

HPB (Oxford). 2018 May;20(5):418-422. doi: 10.1016/j.hpb.2017.10.018. Epub 2018 Feb 3.

13.

Use of Entrustable Professional Activities in the Assessment of Surgical Resident Competency.

Wagner JP, Lewis CE, Tillou A, Agopian VG, Quach C, Donahue TR, Hines OJ.

JAMA Surg. 2018 Apr 1;153(4):335-343. doi: 10.1001/jamasurg.2017.4547.

14.

A Comprehensive Assessment of Accurate Lymph Node Staging and Preoperative Detection in Resected Pancreatic Cancer.

Masuda T, Dann AM, Elliott IA, Baba H, Kim S, Sedarat A, Muthusamy VR, Girgis MD, Joe Hines O, Reber HA, Donahue TR.

J Gastrointest Surg. 2018 Feb;22(2):295-302. doi: 10.1007/s11605-017-3607-7. Epub 2017 Oct 17.

PMID:
29043580
15.

ATR inhibition facilitates targeting of leukemia dependence on convergent nucleotide biosynthetic pathways.

Le TM, Poddar S, Capri JR, Abt ER, Kim W, Wei L, Uong NT, Cheng CM, Braas D, Nikanjam M, Rix P, Merkurjev D, Zaretsky J, Kornblum HI, Ribas A, Herschman HR, Whitelegge J, Faull KF, Donahue TR, Czernin J, Radu CG.

Nat Commun. 2017 Aug 14;8(1):241. doi: 10.1038/s41467-017-00221-3.

16.

Distinction of Risk Factors for Superficial vs Organ-Space Surgical Site Infections After Pancreatic Surgery.

Elliott IA, Chan C, Russell TA, Dann AM, Williams JL, Damato L, Chung H, Girgis MD, Hines OJ, Reber HA, Donahue TR.

JAMA Surg. 2017 Nov 1;152(11):1023-1029. doi: 10.1001/jamasurg.2017.2155.

17.

Evaluation of the 2015 AGA guidelines on pancreatic cystic neoplasms in a large surgically confirmed multicenter cohort.

Ge PS, Muthusamy VR, Gaddam S, Jaiyeola DM, Kim S, Sedarat A, Donahue TR, Hosford L, Wilson RH, Grande DP, Keswani RN, Kushnir VM, Mullady D, Edmundowicz SA, Early DS, Komanduri S, Wani S, Watson RR.

Endosc Int Open. 2017 Mar;5(3):E201-E208. doi: 10.1055/s-0042-122010.

18.

Preoperative Treatment With FOLFIRINOX and Successful Resection for a Patient With Mixed Acinar-Endocrine Carcinoma of the Pancreas.

Sugimoto M, Hines OJ, Dawson DW, Muthusamy VR, Reber HA, Donahue TR.

Pancreas. 2017 Apr;46(4):e32-e34. doi: 10.1097/MPA.0000000000000802. No abstract available.

19.

Histone deacetylase inhibitors provoke a tumor supportive phenotype in pancreatic cancer associated fibroblasts.

Nguyen AH, Elliott IA, Wu N, Matsumura C, Vogelauer M, Attar N, Dann A, Ghukasyan R, Toste PA, Patel SG, Williams JL, Li L, Dawson DW, Radu C, Kurdistani SK, Donahue TR.

Oncotarget. 2017 Mar 21;8(12):19074-19088. doi: 10.18632/oncotarget.13572.

20.

Assessment of a Revised Management Strategy for Patients With Intraductal Papillary Mucinous Neoplasms Involving the Main Pancreatic Duct.

Sugimoto M, Elliott IA, Nguyen AH, Kim S, Muthusamy VR, Watson R, Hines OJ, Dawson DW, Reber HA, Donahue TR.

JAMA Surg. 2017 Jan 18;152(1):e163349. doi: 10.1001/jamasurg.2016.3349. Epub 2017 Jan 18.

PMID:
27829085
21.

A hitherto undescribed benign mesenchymal polyp of the gallbladder: edematous angiomyolipoma-like polyp.

Arcega R, Wu JX, Magaki S, Donahue TR, Wang HL.

Acta Gastroenterol Belg. 2016 Jul-Sep;79(3):245-250.

PMID:
27821035
22.

Leveraging Mechanisms Governing Pancreatic Tumorigenesis To Reduce Pancreatic Cancer Mortality.

Donahue TR, Dawson DW.

Trends Endocrinol Metab. 2016 Nov;27(11):770-781. doi: 10.1016/j.tem.2016.06.009. Epub 2016 Jul 25. Review.

23.

Stiffness of pancreatic cancer cells is associated with increased invasive potential.

Nguyen AV, Nyberg KD, Scott MB, Welsh AM, Nguyen AH, Wu N, Hohlbauch SV, Geisse NA, Gibb EA, Robertson AG, Donahue TR, Rowat AC.

Integr Biol (Camb). 2016 Dec 5;8(12):1232-1245.

24.

Association of Histopathologic Phenotype of Periampullary Adenocarcinomas With Survival.

Williams JL, Chan CK, Toste PA, Elliott IA, Vasquez CR, Sunjaya DB, Swanson EA, Koo J, Hines OJ, Reber HA, Dawson DW, Donahue TR.

JAMA Surg. 2017 Jan 1;152(1):82-88. doi: 10.1001/jamasurg.2016.3466.

PMID:
27732711
25.

Polymicrobial Transjugular Intrahepatic Portosystemic Shunt Infection in the Setting of a Prior Hepaticojejunostomy Anastomosis: A Case Report.

Gupta P, Donahue TR.

Case Rep Pancreat Cancer. 2016 Oct 1;2(1):62-64. doi: 10.1089/crpc.2016.0013. eCollection 2016.

26.

Circulating tumour cells as a biomarker for diagnosis and staging in pancreatic cancer.

Ankeny JS, Court CM, Hou S, Li Q, Song M, Wu D, Chen JF, Lee T, Lin M, Sho S, Rochefort MM, Girgis MD, Yao J, Wainberg ZA, Muthusamy VR, Watson RR, Donahue TR, Hines OJ, Reber HA, Graeber TG, Tseng HR, Tomlinson JS.

Br J Cancer. 2016 Jun 14;114(12):1367-75. doi: 10.1038/bjc.2016.121.

27.

Transcriptomic and CRISPR/Cas9 technologies reveal FOXA2 as a tumor suppressor gene in pancreatic cancer.

Vorvis C, Hatziapostolou M, Mahurkar-Joshi S, Koutsioumpa M, Williams J, Donahue TR, Poultsides GA, Eibl G, Iliopoulos D.

Am J Physiol Gastrointest Liver Physiol. 2016 Jun 1;310(11):G1124-37. doi: 10.1152/ajpgi.00035.2016. Epub 2016 May 5.

28.

Pancreatic Cyst Disease: A Review.

Stark A, Donahue TR, Reber HA, Hines OJ.

JAMA. 2016 May 3;315(17):1882-93. doi: 10.1001/jama.2016.4690. Review.

PMID:
27139061
29.

CA19-9 Normalization During Pre-operative Treatment Predicts Longer Survival for Patients with Locally Progressed Pancreatic Cancer.

Williams JL, Kadera BE, Nguyen AH, Muthusamy VR, Wainberg ZA, Hines OJ, Reber HA, Donahue TR.

J Gastrointest Surg. 2016 Jul;20(7):1331-42. doi: 10.1007/s11605-016-3149-4. Epub 2016 Apr 25.

30.

Plectin-1 as a Biomarker of Malignant Progression in Intraductal Papillary Mucinous Neoplasms: A Multicenter Study.

Moris M, Dawson DW, Jiang J, Lewis J, Nassar A, Takeuchi KK, Lay AR, Zhai Q, Donahue TR, Kelly KA, Crawford HC, Wallace M.

Pancreas. 2016 Oct;45(9):1353-8. doi: 10.1097/MPA.0000000000000652.

31.

[18F]CFA as a clinically translatable probe for PET imaging of deoxycytidine kinase activity.

Kim W, Le TM, Wei L, Poddar S, Bazzy J, Wang X, Uong NT, Abt ER, Capri JR, Austin WR, Van Valkenburgh JS, Steele D, Gipson RM, Slavik R, Cabebe AE, Taechariyakul T, Yaghoubi SS, Lee JT, Sadeghi S, Lavie A, Faull KF, Witte ON, Donahue TR, Phelps ME, Herschman HR, Herrmann K, Czernin J, Radu CG.

Proc Natl Acad Sci U S A. 2016 Apr 12;113(15):4027-32. doi: 10.1073/pnas.1524212113. Epub 2016 Mar 28.

32.

Chemotherapy-Induced Inflammatory Gene Signature and Protumorigenic Phenotype in Pancreatic CAFs via Stress-Associated MAPK.

Toste PA, Nguyen AH, Kadera BE, Duong M, Wu N, Gawlas I, Tran LM, Bikhchandani M, Li L, Patel SG, Dawson DW, Donahue TR.

Mol Cancer Res. 2016 May;14(5):437-47. doi: 10.1158/1541-7786.MCR-15-0348. Epub 2016 Mar 15.

33.

Expression of GRP78, Master Regulator of the Unfolded Protein Response, Increases Chemoresistance in Pancreatic Ductal Adenocarcinoma.

Gifford JB, Huang W, Zeleniak AE, Hindoyan A, Wu H, Donahue TR, Hill R.

Mol Cancer Ther. 2016 May;15(5):1043-52. doi: 10.1158/1535-7163.MCT-15-0774. Epub 2016 Mar 3.

34.

Long-term survival in patients with pancreatic ductal adenocarcinoma.

Stark AP, Sacks GD, Rochefort MM, Donahue TR, Reber HA, Tomlinson JS, Dawson DW, Eibl G, Hines OJ.

Surgery. 2016 Jun;159(6):1520-1527. doi: 10.1016/j.surg.2015.12.024. Epub 2016 Feb 2.

35.

Pancreatic cancer patients with lymph node involvement by direct tumor extension have similar survival to those with node-negative disease.

Williams JL, Nguyen AH, Rochefort M, Muthusamy VR, Wainberg ZA, Dawson DW, Tomlinson JS, Hines OJ, Reber HA, Donahue TR.

J Surg Oncol. 2015 Sep;112(4):396-402. doi: 10.1002/jso.24011. Epub 2015 Aug 25.

PMID:
26303811
36.

Predictors for Surgical Referral in Patients With Pancreatic Cystic Lesions Undergoing Endoscopic Ultrasound: Results From a Large Multicenter Cohort Study.

Ge PS, Gaddam S, Keach JW, Mullady D, Fukami N, Edmundowicz SA, Azar RR, Shah RJ, Murad FM, Kushnir VM, Ghassemi KF, Sedarat A, Watson RR, Amateau SK, Brauer BC, Yen RD, Hosford L, Hollander T, Donahue TR, Schulick RD, Edil BH, McCarter MD, Gajdos C, Attwell AR, Muthusamy VR, Early DS, Wani S.

Pancreas. 2016 Jan;45(1):51-7. doi: 10.1097/MPA.0000000000000386.

PMID:
26262589
37.

Suboptimal accuracy of carcinoembryonic antigen in differentiation of mucinous and nonmucinous pancreatic cysts: results of a large multicenter study.

Gaddam S, Ge PS, Keach JW, Mullady D, Fukami N, Edmundowicz SA, Azar RR, Shah RJ, Murad FM, Kushnir VM, Watson RR, Ghassemi KF, Sedarat A, Komanduri S, Jaiyeola DM, Brauer BC, Yen RD, Amateau SK, Hosford L, Hollander T, Donahue TR, Schulick RD, Edil BH, McCarter M, Gajdos C, Attwell A, Muthusamy VR, Early DS, Wani S.

Gastrointest Endosc. 2015 Dec;82(6):1060-9. doi: 10.1016/j.gie.2015.04.040. Epub 2015 Jun 12.

PMID:
26077458
38.

Pancreatic cancer patient survival correlates with DNA methylation of pancreas development genes.

Thompson MJ, Rubbi L, Dawson DW, Donahue TR, Pellegrini M.

PLoS One. 2015 Jun 3;10(6):e0128814. doi: 10.1371/journal.pone.0128814. eCollection 2015.

39.

p85╬▒ is a microRNA target and affects chemosensitivity in pancreatic cancer.

Toste PA, Li L, Kadera BE, Nguyen AH, Tran LM, Wu N, Madnick DL, Patel SG, Dawson DW, Donahue TR.

J Surg Res. 2015 Jun 15;196(2):285-293. doi: 10.1016/j.jss.2015.02.071. Epub 2015 Mar 6.

40.

Surgical management of pancreatic cancer--pancreaticoduodenectomy.

Donahue TR, Reber HA.

Semin Oncol. 2015 Feb;42(1):98-109. doi: 10.1053/j.seminoncol.2014.12.009. Epub 2014 Dec 9. Review.

PMID:
25726055
41.

Plastic biliary stent patency in patients with locally advanced pancreatic adenocarcinoma receiving downstaging chemotherapy.

Ge PS, Hamerski CM, Watson RR, Komanduri S, Cinnor BB, Bidari K, Klapman JB, Lin CL, Shah JN, Wani S, Donahue TR, Muthusamy VR.

Gastrointest Endosc. 2015 Feb;81(2):360-6. doi: 10.1016/j.gie.2014.08.020. Epub 2014 Oct 16.

PMID:
25442083
42.

Current recommendations for surveillance and surgery of intraductal papillary mucinous neoplasms may overlook some patients with cancer.

Nguyen AH, Toste PA, Farrell JJ, Clerkin BM, Williams J, Muthusamy VR, Watson RR, Tomlinson JS, Hines OJ, Reber HA, Donahue TR.

J Gastrointest Surg. 2015 Feb;19(2):258-65. doi: 10.1007/s11605-014-2693-z. Epub 2014 Nov 6.

43.

Low expression of the E3 ubiquitin ligase CBL confers chemoresistance in human pancreatic cancer and is targeted by epidermal growth factor receptor inhibition.

Kadera BE, Toste PA, Wu N, Li L, Nguyen AH, Dawson DW, Donahue TR.

Clin Cancer Res. 2015 Jan 1;21(1):157-65. doi: 10.1158/1078-0432.CCR-14-0610. Epub 2014 Oct 27.

44.

Mucinous cystic neoplasms of the pancreas: are we overestimating malignant potential?

Nguyen D, Dawson DW, Hines OJ, Reber HA, Donahue TR.

Am Surg. 2014 Oct;80(10):915-9.

PMID:
25264629
45.

Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy.

Sherman MH, Yu RT, Engle DD, Ding N, Atkins AR, Tiriac H, Collisson EA, Connor F, Van Dyke T, Kozlov S, Martin P, Tseng TW, Dawson DW, Donahue TR, Masamune A, Shimosegawa T, Apte MV, Wilson JS, Ng B, Lau SL, Gunton JE, Wahl GM, Hunter T, Drebin JA, O'Dwyer PJ, Liddle C, Tuveson DA, Downes M, Evans RM.

Cell. 2014 Sep 25;159(1):80-93. doi: 10.1016/j.cell.2014.08.007.

46.

Stromal microRNA-21 levels predict response to 5-fluorouracil in patients with pancreatic cancer.

Donahue TR, Nguyen AH, Moughan J, Li L, Tatishchev S, Toste P, Farrell JJ.

J Surg Oncol. 2014 Dec;110(8):952-9. doi: 10.1002/jso.23750. Epub 2014 Aug 17.

47.

The CREB-binding protein inhibitor ICG-001 suppresses pancreatic cancer growth.

Arensman MD, Telesca D, Lay AR, Kershaw KM, Wu N, Donahue TR, Dawson DW.

Mol Cancer Ther. 2014 Oct;13(10):2303-14. doi: 10.1158/1535-7163.MCT-13-1005. Epub 2014 Jul 31.

48.

Assessment of resident operative performance using a real-time mobile Web system: preparing for the milestone age.

Wagner JP, Chen DC, Donahue TR, Quach C, Hines OJ, Hiatt JR, Tillou A.

J Surg Educ. 2014 Nov-Dec;71(6):e41-6. doi: 10.1016/j.jsurg.2014.06.008. Epub 2014 Jul 16. Review.

PMID:
25037504
49.

Resolution of persistent pancreaticopleural fistula after an internal drainage procedure.

Vasquez CR, Chestovich P, Muthusamy VR, Donahue TR.

Am Surg. 2014 Jan;80(1):E19-21. No abstract available.

PMID:
24401504
50.

Locally advanced pancreatic cancer: association between prolonged preoperative treatment and lymph-node negativity and overall survival.

Kadera BE, Sunjaya DB, Isacoff WH, Li L, Hines OJ, Tomlinson JS, Dawson DW, Rochefort MM, Donald GW, Clerkin BM, Reber HA, Donahue TR.

JAMA Surg. 2014 Feb;149(2):145-53. doi: 10.1001/jamasurg.2013.2690.

PMID:
24306217

Supplemental Content

Loading ...
Support Center